Markets
BSE See NSE See 29,409.52
176.08 (0.6%)
collapse Related Readings collapse

US FDA’s Alert On Wockhardt: Much Ado About Nothing?

| 5/30/2013 9:02 PM Thursday

Pharma giant Wockhardt has received a strong setback after the US FDA sounded an alert on its Waluj manufacturing facility, after which the stock was hammered by more than 25 per cent in just two trading sessions. The market, however, seems to be overreacting to these developments. Shrikant Akolkar tells us more.

One of the worst things to happen to any stock is for it to get hit by factors which are apparently serious but on deeper exploration seem to be routine. This happens chiefly due to investors’ knee-jerk reaction to news flows which creates humongous negativity around it. One company which has recently been hit by this syndrome is Wockhardt.

We had recommended Wockhardt in DSIJ Vol. 28, Issue # 9 (dated 21 April, 2013) in our cover story ‘Cherry Picking’. The scrip was severely hammered following the recent US FDA alert on its manufacturing facility located in Waluj, Aurangabad district of Maharashtra. In just two trading sessions alone (May 23 and 24, 2013) it lost more than 25 per cent in value. Currently, the stock is down 35 per cent from where we had recommended it. Investors who have acted on our advice would surely be jittery in the wake of such a slide in the stock’s price. What should their future course in this counter be? Should one sell and book losses or wait out the depression? Here are the answers that you would be looking out for.

To start with, the hammering of the stock was a knee-jerk reaction arising out of fears fuelled by a particular event. This fear was accentuated by many other factors that were external to the company. The principal factor among these was the developments in Ranbaxy earlier in the same week.

Ranbaxy, the pharma company now owned by Daichhi Sankyo, pleaded guilty before the United States Department of Justice on compliance related issues in two of its manufacturing facilities. This was in any case weighing heavily on pharma stocks. The alert on Wockhardt’s Waluj facility came immediately after this, and dampened the sentiment on the stock.

What is worth noting is that Ranbaxy had ignored earlier malpractices, the consequences of which it had to bear. Wockhardt, however, had invited the US FDA team to audit its new injectables unit at Waluj. This is what differentiates between the two companies.

Find More Articles on: DSIJ Magazine, Special Report, Stock Recommendations, Fundamental Picks, Product, Large Cap

«« First « Previous |1 2 | Last ››
news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ
Mindshare

BSE to suspend 7 company’s trading for non-compliance of Regulation 55A

BSE to suspend 7 company’s trading for non-compliance of Regulation 55A

BSE will suspend seven companies from trading their securities on the stock exchange from April 18 for failing to comply with certain rules for two consecutive quarters.

43 CPSEs in the red since last 3 years, informs MoS

43 CPSEs in the red since last 3 years, informs MoS

Babul Surpiyo, Minister of State for Heavy Industries and Public Entreprises, informed the parliament today that there are as many as 43 central public sector enterprises (CPSEs) which includes Air India and BSNL that are making losses over the last three consecutive years.

Skymet Weather forecasts 95% monsoon in 2017

Skymet Weather forecasts 95% monsoon in 2017

According to Skymet Weather forecast, monsoon in India this year is likely to remain below normal at 95 per cent (with an error margin of +/-5 per cent).

Overnight Digest- Stocks to look out for on March 29

Overnight Digest- Stocks to look out for on March 29

The stocks which are expected to witness significant movement on March 29 are Karnataka Bank, Britannia, V-Guard Industries, ICICI Bank, Nestle India.

SBI spends Rs 775 crore to maintain Jan Dhan accounts!

SBI spends Rs 775 crore to maintain Jan Dhan accounts!

The total balance in PMJDY stood at Rs 71,036 crore as on December 28, 2016. Divulging further details, the MoS informed that public sector banks, regional banks and 13 private banks have reported that nearly 95,52,609 accounts were frozen under the PMJDY.

Market
CHIT CHAT

What is your view on markets today?

200  Characters Remaining.
Please LOGIN  to post your comments or Click here to go back.
punkesh kumar Mar 29 01:28AM
How do i buy a stock
amarjeet jaiswal Mar 29 12:08AM
Network 985725 cash balance 1000737.74 my actual balance is what please tell me
shiv kumar Mar 28 08:39PM
What happened to iol chemical??
karthick ponraj Mar 28 04:06PM
Cannot cover short stocks within 4 clock on next day cannot order for short
The King Mar 28 03:24PM
not sure @senthil, each day in mkt is diff.